The Company develops, manufactures, licenses and markets a range of products serving the aesthetic market, including plastic and reconstructive surgery.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
They are concentrating on aesthetic medicine (wrinkle removal and breast augmentation) and have gotten rid of their other two segments. Whether they can make this focusing work or not remains to be seen.
It's a baby boomer thing. As the population ages, this segment will continue to do well. The 50-75 year olds have money and want to stay young. MNT provides a way to do that, or at least fake it. It's a pretty selfish generation (I can say this because I'm IN it), and they will spend their money on themselves.